Patents Assigned to BOYUAN RUNSHENG PHARMA (HANGZHOU) CO., LTD.
  • CSPG4-TARGETING HUMANIZED CHIMERIC ANTIGEN RECEPTOR, IMMUNE EFFECTOR CELL EXPRESSING CHIMERIC ANTIGEN RECEPTOR, AND APPLICATIONS THEREOF
    Publication number: 20230357355
    Abstract: Related are a CSPG4-targeting humanized chimeric antigen receptor and applications thereof, comprising a humanized anti-CSPG4 binding domain, a hinge region, a transmembrane domain, and a signal transduction domain. The anti-CSPG4 binding domain comprises an anti-CSPG4 antibody or antigen binding part. Related are an immune effector cell expressing the CSPG4-targeting humanized chimeric antigen receptor and applications of the cell.
    Type: Application
    Filed: September 23, 2021
    Publication date: November 9, 2023
    Applicant: BOYUAN RUNSHENG PHARMA (HANGZHOU) CO., LTD.
    Inventors: Chuang SUN, Xin-Hua FENG, Bin ZHAO